Fuseau E - Search Results

1

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E. Perucca E, et al. Among authors: fuseau e. Epilepsia. 2008 Jul;49(7):1123-41. doi: 10.1111/j.1528-1167.2008.01665.x. Epilepsia. 2008. PMID: 18503564 Free article.

2

Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation.

Marchand M, Fuseau E, Critchley DJ. Marchand M, et al. Among authors: fuseau e. J Pharmacokinet Pharmacodyn. 2010 Feb;37(1):99-118. doi: 10.1007/s10928-009-9146-4. J Pharmacokinet Pharmacodyn. 2010. PMID: 20084538

3

Pharmacokinetics of sumatriptan nasal spray in adolescents.

Christensen ML, Mottern RK, Jabbour JT, Fuseau E. Christensen ML, et al. Among authors: fuseau e. J Clin Pharmacol. 2003 Jul;43(7):721-6. J Clin Pharmacol. 2003. PMID: 12856385 Clinical Trial.

4

Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine.

Christensen ML, Eades SK, Fuseau E, Kempsford RD, Phelps SJ, Hak LJ. Christensen ML, et al. Among authors: fuseau e. J Clin Pharmacol. 2001 Feb;41(2):170-5. doi: 10.1177/00912700122009980. J Clin Pharmacol. 2001. PMID: 11210397 Clinical Trial.

5

Clinical pharmacokinetics of intranasal sumatriptan.

Fuseau E, Petricoul O, Moore KH, Barrow A, Ibbotson T. Fuseau E, et al. Clin Pharmacokinet. 2002;41(11):801-11. doi: 10.2165/00003088-200241110-00002. Clin Pharmacokinet. 2002. PMID: 12190330 Review.

6

Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.

EL Desoky ES, Fuseau E, EL Din Amry S, Cosson V. EL Desoky ES, et al. Among authors: fuseau e. Eur J Clin Pharmacol. 2004 Jan;59(11):783-90. doi: 10.1007/s00228-003-0699-7. Epub 2003 Dec 12. Eur J Clin Pharmacol. 2004. PMID: 14673555

7

Pharmacokinetics, drug interactions and exposure-response relationship of eslicarbazepine acetate in adult patients with partial-onset seizures: population pharmacokinetic and pharmacokinetic/pharmacodynamic analyses.

Falcão A, Fuseau E, Nunes T, Almeida L, Soares-da-Silva P. Falcão A, et al. Among authors: fuseau e. CNS Drugs. 2012 Jan 1;26(1):79-91. doi: 10.2165/11596290-000000000-00000. CNS Drugs. 2012. PMID: 22171585 Review.

8

Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration.

Duquesnoy C, Mamet JP, Sumner D, Fuseau E. Duquesnoy C, et al. Among authors: fuseau e. Eur J Pharm Sci. 1998 Apr;6(2):99-104. doi: 10.1016/s0928-0987(97)00073-0. Eur J Pharm Sci. 1998. PMID: 9795022 Clinical Trial.

9

Pharmacokinetics of sumatriptan nasal spray in children.

Christensen ML, Mottern RK, Jabbour JT, Fuseau E. Christensen ML, et al. Among authors: fuseau e. J Clin Pharmacol. 2004 Apr;44(4):359-67. doi: 10.1177/0091270004263467. J Clin Pharmacol. 2004. PMID: 15051742 Clinical Trial.

10

Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.

Berlin I, Rosenzweig P, Chalon S, Fuseau E, Landault C, Cesselin F, Blacker C, Puech AJ. Berlin I, et al. Among authors: fuseau e. Clin Pharmacol Ther. 1994 Mar;55(3):338-45. doi: 10.1038/clpt.1994.35. Clin Pharmacol Ther. 1994. PMID: 7908257 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters